These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22339047)

  • 1. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
    Ma Y; Roy S; Kong X; Chen Y; Liu D; Hider RC
    J Med Chem; 2012 Mar; 55(5):2185-95. PubMed ID: 22339047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
    J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterizations of pyridazine-based iron chelators.
    Ma Y; Kong X; Chen YL; Hider RC
    Dalton Trans; 2014 Dec; 43(45):17120-8. PubMed ID: 25311299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel pegylated iron chelators with decreased metabolic rate.
    Li J; Lu Z; Kong X; Ma Y; Zhang X; Bansal SS; Abbate V; Hider RC
    Future Med Chem; 2015; 7(18):2439-49. PubMed ID: 26670054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier.
    Roy S; Preston JE; Hider RC; Ma YM
    J Med Chem; 2010 Aug; 53(15):5886-9. PubMed ID: 20684616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
    Liu ZD; Khodr HH; Liu DY; Lu SL; Hider RC
    J Med Chem; 1999 Nov; 42(23):4814-23. PubMed ID: 10579844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
    Liu ZD; Liu DY; Lu SL; Hider RC
    Arzneimittelforschung; 2000 May; 50(5):461-70. PubMed ID: 10858874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxy(thio)pyrone and hydroxy(thio)pyridinone iron chelators: physico-chemical properties and anti-oxidant activity.
    Chaves S; Canário S; Carrasco MP; Mira L; Santos MA
    J Inorg Biochem; 2012 Sep; 114():38-46. PubMed ID: 22687564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amido-3-hydroxypyridin-4-ones as iron(III) ligands.
    Piyamongkol S; Ma YM; Kong XL; Liu ZD; Aytemir MD; van der Helm D; Hider RC
    Chemistry; 2010 Jun; 16(21):6374-81. PubMed ID: 20397153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
    Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
    J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
    Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors.
    Ma Y; Luo W; Quinn PJ; Liu Z; Hider RC
    J Med Chem; 2004 Dec; 47(25):6349-62. PubMed ID: 15566304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS; Liu ZD; Hider RC
    Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
    Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
    J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD; Khodr HH; Lu SL; Hider RC
    J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
    Gama S; Gil M; Gano L; Farkas E; Amélia Santos M
    J Inorg Biochem; 2009 Feb; 103(2):288-98. PubMed ID: 19091421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
    Liu ZD; Liu DY; Lu SL; Hider RC
    J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
    Kontoghiorghes GJ; Sheppard L; Chambers S
    Arzneimittelforschung; 1987 Oct; 37(10):1099-102. PubMed ID: 3435580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
    Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC
    J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease.
    Gaeta A; Molina-Holgado F; Kong XL; Salvage S; Fakih S; Francis PT; Williams RJ; Hider RC
    Bioorg Med Chem; 2011 Feb; 19(3):1285-97. PubMed ID: 21236688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.